Secondary

9 registered clinical trials studyying Secondary.

Status	Trial	Sponsor	Phase
Completed	Study of SECOX Versus Sorafenib as First-Line Treatment in Patients With Advanced Hepatocellular Carcinoma (HC NCT02716766	The University of Hong Kong	Phase 2
Terminated	Open-label, Multicenter, Randomized Phase II Trial of Treatment With Cisplatin and Pemetrexed or Cisplatin and NCT02919462	Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS	Phase 2
Withdrawn	Vaccination With Dendritic Cells Pulsed With Autologous Tumor Homogenate in Combination With HD-IL2 and Immuno NCT03226236	Istituto Romagnolo per lo Studio dei Tumori Dino Amadori IRST S.r.l. IRCCS	Phase 2
Completed	MRD/Risk-oriented Therapy of Adult Ph- ALL Including Pegylated Asparaginase and Lineage-targeted Methotrexate NCT02067143	Gruppo Italiano Malattie EMatologiche dell'Adulto	Phase 2
Completed	Pilot Imaging Study With 89Zr-Trastuzumab in HER2-positive Metastatic Breast Cancer Patients NCT01420146	Jules Bordet Institute	Phase 1
Unknown	Phase II Study of Irinotecan,Oxaliplatin Plus TS-1 in Untreated Metastatic Colorectal Cancer NCT00506571	National Cancer Center, Korea	Phase 2
Unknown	A Phase I Study of S-1 Plus Irinotecan and Oxaliplatin in Advanced Gastrointestinal Malignancy NCT00506207	National Cancer Center, Korea	Phase 1
Unknown	Study of Genetic Polymorphisms of Drug Transporters and Orphan Nuclear Receptors on Treatment Effects of Irino NCT00507143	National Cancer Center, Korea	N/A
Terminated	Study of Irinotecan & Capecitabine in Metastatic Colorectal Cancer NCT00506168	National Cancer Center, Korea	Phase 2